Loading...

Donna Shoupe, MD

Title(s)Professor of Obstetrics & Gynecology
AddressIRD 534 2020 Zonal Ave
Off Campus
Los Angeles CA 90033
Phone+1 323 226 3351
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer. Gynecol Oncol. 2019 07; 154(1):45-52. Mandelbaum RS, Chen L, Shoupe D, Paulson RJ, Roman LD, Wright JD, Matsuo K. PMID: 31036348.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause. J Clin Endocrinol Metab. 2019 02 01; 104(2):293-300. Sriprasert I, Hodis HN, Karim R, Stanczyk FZ, Shoupe D, Henderson VW, Mack WJ. PMID: 30272234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer. Obstet Gynecol. 2017 01; 129(1):139-151. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, Wright JD. PMID: 27926642.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer. Obstet Gynecol. 2016 10; 128(4):761-70. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, Wright JD. PMID: 27607873.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. The effect of home exercise on ovulation induction using clomiphene citrate in overweight underserved women with polycystic ovarian syndrome. Contracept Reprod Med. 2016; 1:14. Nagelberg J, Burks H, Mucowski S, Shoupe D. PMID: 29201403.
      View in: PubMed   Mentions:
    6. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology. 2016 Aug 16; 87(7):699-708. Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ. PMID: 27421538.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    7. Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence. Cancer Prev Res (Phila). 2016 Sep; 9(9):713-20. Sherman ME, Drapkin RI, Horowitz NS, Crum CP, Friedman S, Kwon JS, Levine DA, Shih IeM, Shoupe D, Swisher EM, Walker J, Trabert B, Greene MH, Samimi G, Temkin SM, Minasian LM. PMID: 27221539.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Contributing factors for menopausal symptoms after surgical staging for endometrial cancer. Menopause. 2016 05; 23(5):535-43. Matsuo K, Gualtieri MR, Cahoon SS, Toboni MD, Machida H, Moeini A, Hasegawa K, Shoupe D, Roman LD. PMID: 26757269.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. N Engl J Med. 2016 Mar 31; 374(13):1221-31. Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP. PMID: 27028912.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    10. LARC methods: entering a new age of contraception and reproductive health. Contracept Reprod Med. 2016; 1:4. Shoupe D. PMID: 29201394.
      View in: PubMed   Mentions:
    11. Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. Menopause. 2016 Feb; 23(2):189-96. Matsuo K, Gualtieri MR, Cahoon SS, Jung CE, Paulson RJ, Shoupe D, Muderspach LI, Wakatsuki A, Wright JD, Roman LD. PMID: 26173075.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Surgical Menopause. Endocrinol Metab Clin North Am. 2015 Sep; 44(3):531-42. Rodriguez M, Shoupe D. PMID: 26316241.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Menopause. 2015 Apr; 22(4):391-401. Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW. PMID: 25380275.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    14. Hormone replacement therapy: consensus and controversies. Panminerva Med. 2014; 56(4):263-72. Shoupe D. PMID: 25288326.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Effect of prior oophorectomy on changes in bone mineral density and carotid artery intima-media thickness in postmenopausal women. Fertil Steril. 2014 Apr; 101(4):1117-22. Mucowski SJ, Mack WJ, Shoupe D, Kono N, Paulson R, Hodis HN. PMID: 24530156.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Individualizing hormone-therapy according to cardiovascular risk. Minerva Ginecol. 2013 Dec; 65(6):631-9. Shoupe D. PMID: 24346251.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A. 2013 Dec 10; 110(50):20290-5. Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Karim R, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ. PMID: 24277815.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    18. In reply. Obstet Gynecol. 2013 Aug; 122(2 Pt 1):396. Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM, Berek JS, Manson JE. PMID: 23969818.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial. Menopause. 2013 Aug; 20(8):840-4. Quaas AM, Kono N, Mack WJ, Hodis HN, Felix JC, Paulson RJ, Shoupe D. PMID: 23422867.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol. 2013 Apr; 121(4):709-16. Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM, Berek JS, Manson JE. PMID: 23635669.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    21. Individualizing hormone-therapy according to cardiovascular risk. Minerva Med. 2012 Oct; 103(5):343-52. Shoupe D. PMID: 23042369.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial. Stroke. 2011 Nov; 42(11):3168-75. Hodis HN, Mack WJ, Kono N, Azen SP, Shoupe D, Hwang-Levine J, Petitti D, Whitfield-Maxwell L, Yan M, Franke AA, Selzer RH. PMID: 21903957.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    23. Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits. Womens Health (Lond). 2011 Jul; 7(4):475-85. Shoupe D. PMID: 21790340.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond). 2009 Sep; 5(5):565-76. Parker WH, Jacoby V, Shoupe D, Rocca W. PMID: 19702455.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    25. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol. 2009 May; 113(5):1027-37. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE. PMID: 19384117.
      View in: PubMed   Mentions: 134     Fields:    Translation:Humans
    26. Elective oophorectomy in the gynecological patient: when is it desirable? Curr Opin Obstet Gynecol. 2007 Aug; 19(4):350-4. Parker WH, Shoupe D, Broder MS, Liu Z, Farquhar C, Berek JS. PMID: 17625417.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Ovarian conservation at the time of hysterectomy for benign disease. Clin Obstet Gynecol. 2007 Jun; 50(2):354-61. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. PMID: 17513923.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    28. Elective oophorectomy for benign gynecological disorders. Menopause. 2007 May-Jun; 14(3 Pt 2):580-5. Shoupe D, Parker WH, Broder MS, Liu Z, Farquhar C, Berek JS. PMID: 17476148.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    29. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials. Obstet Gynecol. 2007 Mar; 109(3):581-7. Steiner AZ, Xiang M, Mack WJ, Shoupe D, Felix JC, Lobo RA, Hodis HN. PMID: 17329508.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial. Menopause. 2005 Nov-Dec; 12(6):728-33. Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ. PMID: 16278616.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005 Aug; 106(2):219-26. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. PMID: 16055568.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    32. A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol. Maturitas. 2004 Oct 15; 49(2):140-7. Gass MS, Rebar RW, Cuffie-Jackson C, Cedars MI, Lobo RA, Shoupe D, Judd HL, Buyalos RP, Clisham PR. PMID: 15474758.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    33. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril. 2004 Aug; 82(2):391-7. Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN. PMID: 15302289.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    34. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med. 2003 Aug 07; 349(6):535-45. Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH. PMID: 12904518.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    35. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001 Dec 04; 135(11):939-53. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP. PMID: 11730394.
      View in: PubMed   Mentions: 143     Fields:    Translation:HumansCTClinical Trials
    36. Comparison of estrogen and androgen levels after oral estrogen replacement therapy. J Reprod Med. 2001 Dec; 46(12):1052-6. Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, Paulson RJ, Stanczyk FZ. PMID: 11789085.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    37. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril. 2001 Jun; 75(6):1065-79. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. PMID: 11384629.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCTClinical Trials
    38. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women. Menopause. 2001 May-Jun; 8(3):200-3. Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, Stanczyk FZ. PMID: 11355042.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    39. HRT dosing regimens: continuous versus cyclic-pros and cons. Int J Fertil Womens Med. 2001 Jan-Feb; 46(1):7-15. Shoupe D. PMID: 11294619.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    40. Hysterectomy or an alternative? Hosp Pract (1995). 2000 Sep 15; 35(9):55-62; quiz 92. Shoupe D. PMID: 11004927.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000 Jan 25; 54(2):295-301. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR. PMID: 10668686.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCTClinical Trials
    42. Hormone replacement therapy: reassessing the risks and benefits. Hosp Pract (1995). 1999 Aug 15; 34(8):97-103, 107-8, 113-4. Shoupe D. PMID: 10459365.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Androgens and bone: clinical implications for menopausal women. Am J Obstet Gynecol. 1999 Mar; 180(3 Pt 2):S329-33. Shoupe D. PMID: 10076175.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Phase I prehysterectomy studies of the transcervical administration of quinacrine pellets. Contraception. 1996 Sep; 54(3):181-6. Laufe LE, Sokal DC, Cole LP, Shoupe D, Schenken RS. PMID: 8899260.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    45. Contraception in the 1990s. Curr Opin Obstet Gynecol. 1996 Jun; 8(3):211-5. Shoupe D. PMID: 8818532.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone. J Soc Gynecol Investig. 1996 Mar-Apr; 3(2):93-8. Rapkin AJ, Shoupe D, Reading A, Daneshgar KK, Goldman L, Bohn Y, Brann DW, Mahesh VB. PMID: 8796815.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    47. A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol. Contraception. 1994 Dec; 50(6):517-33. Ballagh SA, Mishell DR, Lacarra M, Shoupe D, Jackanicz TM, Eggena P. PMID: 7705095.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    48. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril. 1994 Nov; 62(5):932-7. Mezrow G, Shoupe D, Spicer D, Lobo R, Leung B, Pike M. PMID: 7926137.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    49. New progestins--clinical experiences: gestodene. Am J Obstet Gynecol. 1994 May; 170(5 Pt 2):1562-8. Shoupe D. PMID: 8178907.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone. Obstet Gynecol. 1994 May; 83(5 Pt 1):679-85. Shoupe D. PMID: 8164925.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    51. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994 Mar 16; 86(6):431-6. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC. PMID: 8120917.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    52. Luteal phase defects. J Reprod Med. 1993 May; 38(5):348-56. Bopp B, Shoupe D. PMID: 8320670.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer. Contraception. 1993 May; 47(5):427-44. Spicer DV, Pike MC, Pike A, Rude R, Shoupe D, Richardson J. PMID: 8390340.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    54. Prevention of vaginal trichomoniasis by compliant use of the female condom. Sex Transm Dis. 1993 May-Jun; 20(3):137-9. Soper DE, Shoupe D, Shangold GA, Shangold MM, Gutmann J, Mercer L. PMID: 8511706.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    55. Effects of desogestrel on carbohydrate metabolism. Am J Obstet Gynecol. 1993 Mar; 168(3 Pt 2):1041-7. Shoupe D. PMID: 8447358.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    56. Prevention of endometrial hyperplasia in postmenopausal women with intrauterine progesterone. N Engl J Med. 1991 Dec 19; 325(25):1811-2. Shoupe D, Meme D, Mezrow G, Lobo RA. PMID: 1944490.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Gonadotropin-releasing hormone agonist plus add-back sex steroids to reduce risk of breast cancer. J Natl Cancer Inst. 1991 Dec 04; 83(23):1763. Spicer D, Shoupe D, Pike M. PMID: 1770556.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer. Contraception. 1991 Sep; 44(3):289-310. Spicer DV, Shoupe D, Pike MC. PMID: 1662596.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Postmenopausal hormone replacement with a combination estrogen-progestin regimen for five days per week. J Reprod Med. 1991 May; 36(5):351-5. Mishell DR, Shoupe D, Moyer DL, Roy S, Page MA. PMID: 2061882.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    60. Characteristics of ovarian follicular development in Norplant users. Fertil Steril. 1991 Apr; 55(4):766-70. Shoupe D, Horenstein J, Mishell DR, Lacarra M, Medearis A. PMID: 1901281.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. The significance of bleeding patterns in Norplant implant users. Obstet Gynecol. 1991 Feb; 77(2):256-60. Shoupe D, Mishell DR, Bopp BL, Fielding M. PMID: 1899135.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. Contraceptive options for the gestational diabetic woman. Int J Fertil. 1991; 36 Suppl 2:80-4; discussion 84-6. Shoupe D, Bopp B. PMID: 1679421.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. Am J Obstet Gynecol. 1990 Dec; 163(6 Pt 1):1822-7. Kjos SL, Shoupe D, Douyan S, Friedman RL, Bernstein GS, Mestman JH, Mishell DR. PMID: 2256489.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    64. Antiprogestin treatment decreases midluteal luteinizing hormone pulse amplitude and primarily exerts a pituitary inhibition. Am J Obstet Gynecol. 1990 Dec; 163(6 Pt 1):1982-5. Shoupe D, Mishell DR, Fossum G, Bopp BL, Spitz IM, Lobo RA. PMID: 2256511.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    65. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception. 1990 Oct; 42(4):361-78. Sivin I, el Mahgoub S, McCarthy T, Mishell DR, Shoupe D, Alvarez F, Brache V, Jimenez E, Diaz J, Faundes A. PMID: 2124179.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    66. Predictors of failed attempted abortion with the antiprogestin mifepristone (RU 486). Am J Obstet Gynecol. 1990 Apr; 162(4):910-5; discussion 915-7. Grimes DA, Bernstein L, Lacarra M, Shoupe D, Mishell DR. PMID: 2183618.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Norplant: subdermal implant system for long-term contraception. Am J Obstet Gynecol. 1989 May; 160(5 Pt 2):1286-92. Shoupe D, Mishell DR. PMID: 2497646.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    68. Correlation of endometrial maturation with four methods of estimating day of ovulation. Obstet Gynecol. 1989 Jan; 73(1):88-92. Shoupe D, Mishell DR, Lacarra M, Lobo RA, Horenstein J, d'Ablaing G, Moyer D. PMID: 2642330.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    69. Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women. J Reprod Fertil Suppl. 1989; 37:253-60. Spitz IM, Shoupe D, Sitruk-Ware R, Mishell DR. PMID: 2681741.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    70. A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol. 1988 Dec; 159(6):1540-6. Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA, Lobo RA. PMID: 3144919.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    71. Early abortion with a single dose of the antiprogestin RU-486. Am J Obstet Gynecol. 1988 Jun; 158(6 Pt 1):1307-12. Grimes DA, Mishell DR, Shoupe D, Lacarra M. PMID: 2454578.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    72. Effects of oral contraceptives on the borderline NIDD patient. Int J Fertil. 1988; 33 Suppl:27-34. Shoupe D, Kjos S. PMID: 2908038.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    73. Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase. Am J Obstet Gynecol. 1987 Dec; 157(6):1415-20. Shoupe D, Mishell DR, Lahteenmaki P, Heikinheimo O, Birgerson L, Madkour H, Spitz IM. PMID: 2827481.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase. Am J Obstet Gynecol. 1987 Dec; 157(6):1421-6. Shoupe D, Mishell DR, Page MA, Madkour H, Spitz IM, Lobo RA. PMID: 2827482.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    75. Metabolism and serum binding of RU 486 in women after various single doses. Hum Reprod. 1987 Jul; 2(5):379-85. Heikinheimo O, Lähteenmäki PL, Koivunen E, Shoupe D, Croxatto H, Luukkainen T, Lähteenmäki P. PMID: 3654927.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    76. Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose. Contraception. 1987 Apr; 35(4):307-21. Mishell DR, Shoupe D, Brenner PF, Lacarra M, Horenstein J, Lahteenmaki P, Spitz IM. PMID: 3621937.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Pharmacokinetics and metabolism of RU 486. J Steroid Biochem. 1987; 27(4-6):859-63. Lähteenmäki P, Heikinheimo O, Croxatto H, Spitz I, Shoupe D, Birgerson L, Luukkainen T. PMID: 3695508.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    78. Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography. Contraception. 1986 Dec; 34(6):613-24. Heikinheimo O, Tevilin M, Shoupe D, Croxatto H, Lähteenmäki P. PMID: 3829676.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception. 1986 Sep; 34(3):261-7. Belhadj H, Sivin I, Diaz S, Pavez M, Tejada AS, Brache V, Alvarez F, Shoupe D, Breaux H, Mishell DR. PMID: 3098498.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    80. Pregnancy termination with a high and medium dosage regimen of RU 486. Contraception. 1986 May; 33(5):455-61. Shoupe D, Mishell DR, Brenner PF, Spitz IM. PMID: 3757511.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    81. Ovulation inhibition with nafarelin acetate nasal administration for six months. Contraception. 1985 Dec; 32(6):531-51. Brenner PF, Shoupe D, Mishell DR. PMID: 2936564.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    82. Dose-related changes in LH bioactivity with intranasal GnRH agonist administration. Contraception. 1985 Oct; 32(4):347-57. Chiang RS, Barnes RB, Shoupe D, Lobo RA. PMID: 2934222.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    83. Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgically-induced postmenopausal women. Horm Metab Res. 1985 Jul; 17(7):370-3. Lobo RA, Roy S, Shoupe D, Endres DB, Adams JS, Rude RK, Singer FR. PMID: 3161813.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    84. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome. Fertil Steril. 1985 Apr; 43(4):549-53. Shoupe D, Lobo RA. PMID: 3921411.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril. 1985 Feb; 43(2):200-5. Lobo RA, Shoupe D, Serafini P, Brinton D, Horton R. PMID: 3967781.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    86. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab. 1985 Jan; 60(1):178-83. Shoupe D, Montz FJ, Lobo RA. PMID: 2981084.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    87. Evidence for altered catecholamine metabolism in polycystic ovary syndrome. Am J Obstet Gynecol. 1984 Nov 01; 150(5 Pt 1):566-71. Shoupe D, Lobo RA. PMID: 6437227.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    88. Priming with gonadotropin-releasing hormone restores gonadotropin secretion during first but not second trimester of pregnancy. Am J Obstet Gynecol. 1984 Nov 01; 150(5 Pt 1):460-4. Shoupe D, Kletzky OA. PMID: 6437225.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    89. Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women. Am J Obstet Gynecol. 1984 Jul 01; 149(5):548-52. Lobo RA, Shoupe D, Roy S, Paul W. PMID: 6742025.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    90. Differences in the ratio of bioactive to immunoreactive serum luteinizing hormone during vasomotor flushes and hormonal therapy in postmenopausal women. J Clin Endocrinol Metab. 1984 May; 58(5):925-9. Chang SP, Shoupe D, Kletzky OA, Lobo RA. PMID: 6323519.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    91. The influence of androgens on insulin resistance. Fertil Steril. 1984 Mar; 41(3):385-8. Shoupe D, Lobo RA. PMID: 6230259.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    92. The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome. Am J Obstet Gynecol. 1984 Feb 15; 148(4):423-8. Lobo RA, Shoupe D, Chang SP, Campeau J. PMID: 6364811.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    93. Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol. 1983 Nov 01; 147(5):588-92. Shoupe D, Kumar DD, Lobo RA. PMID: 6227251.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    94. Prolactin molecular heterogeneity. Response to thyrotropin-releasing hormone stimulation of concanavalin A-bound and -unbound immunoassayable prolactin during human pregnancy. Am J Obstet Gynecol. 1983 Nov 01; 147(5):482-7. Shoupe D, Montz FJ, Kletzky OA, diZerega GS. PMID: 6416070.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Donna's Networks
    Concepts (325)
    Derived automatically from this person's publications.
    _
    Co-Authors (22)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _